Treatment of neuropathic pain in neurology units. The PREVADOL study;Tratamiento del dolor neuropático en las consultas de neurología. Estudio PREVADOL

Revista de Neurologia

Volumn 42, Issue 8, 2006, Pages 451-454

  Pardo Fernandez J ^a   Gutiérrez Rivas, Eduardo ^b   Montero Homs, J ^c   Navarro, C ^d  

^a Pediatric Nutrition Research Group Health Research Institute of Santiago de Compostela   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d Departamento Médico   (Spain)

Author keywords

Antidepressants; Antiepileptic drugs; Neurology units; Neuropathic pain; Non pharmacological treatment; Pharmacological treatment

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; GABAPENTIN; OXCARBAZEPINE; ANALGESIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; MALE; MEDICAL RESEARCH; MONOTHERAPY; NEUROPATHIC PAIN; PHYSIOTHERAPIST; AGED; HOSPITAL DEPARTMENT; MIDDLE AGED; NEURALGIA; NEUROLOGY; POLYPHARMACY; SPAIN;

ADULT; AGED; ANALGESICS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; FEMALE; HOSPITAL DEPARTMENTS; HUMANS; MALE; MIDDLE AGED; NEURALGIA; NEUROLOGY; POLYPHARMACY; SPAIN;

EID: 33750103362     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4208.2005636     Document Type: Article

References (14)

1. Merskey H, Bogduk N. Task force on taxonomy of the International Association for the Study of Pain: classification of chronic pain. Description of pain syndromes and definitions of pain terms. Seattle: IASP Press; 1994.
2. Montero J. ¿Qué es el dolor neuropático? Continua Neurológica 2000; 3: 1-10
3. Serra J. Overview of neuropathic pain syndromes. Acta Neurol Scand 1999; 173: 7-11.
4. Montero J, Gutiérrez-Rivas E, Pardo J, Navarro C. Estudio de prevalencia, incidencia y caracterización del dolor neuropático en consultas de neurología. Estudio PREVADOL. Neurología 2006; 20: 385-9.
5. Harden N, Cohen M. Unmet needs in the management of neuropathic pain. J Pain Symptom Manag 2003; 25: 12-7.
6. Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett GJ, et al. Advances in neuropathic pain. Diagnosis, mechanisms and treatment recommendations. Arch Neurol 2003; 60: 1524-34.
7. Aguilera-Muñoz J, Arizaga-Cueta E, Carpio-Rodas A, Crump J, Díaz-Heredia F, Fernández CF, et al. Guías de práctica clínica del dolor neuropático (II). Rev Neurol 2005; 40: 303-16.
8. Meyer-Rosberg K, Kvarnström A, Kinnman E, Gordh T, Nordfors LO, Kristofferson A. Peripheral neuropathic pain -a multidimensional burden for patients. Eur J Pain 2001; 5: 379-89.
9. Gilron I, Bailey J, Weaver DF, Houlden RL. Patients' attitudes and prior treatments in neuropathic pain: a pilot study. Pain Res Manag 2002; 7: 199-203.
10. Berger A, Dukes EM, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain 2004; 5: 143-9.
11. Baron R, Binder A. How neuropathic is ciatica? The mixed pain concept. Orthopade 2004; 33: 568-75.
12. Sindrup SH, Jensen TS. Pharmacotherapy of trigeminal neuralgia. Clin J Pain 2002; 18: 22-7.
13. Dubinsky RM, Kabbani H, El-Chami Z, Boutwell C, Ali H. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004; 63: 959-65.
14. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998; 280: 1831-6.